Maria Carmen Martorelli

Author

Federico II University Hospital

Also Known As

Maria Carmen Martorelli

Publications

443

Citations

H-Index

Concepts

All Affiliations

Federico II University Hospital Centro di Riferimento Oncologico della Basilicata Istituti di Ricovero e Cura a Carattere Scientifico Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona University of Salerno

About

Maria Carmen Martorelli is an author at Federico II University Hospital specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	76
2	Immunology	2	2	43
3	Health Sciences	1	1	16
4	Natural Sciences	1	1	17
5	Biochemistry	1	1	17

Maria Carmen Martorelli

Publications

219

Citations

H-Index

Page 1

	Year	Citations
Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study Giovanni D’Arena, Paolo G. Gobbi, Chiara Broglia, Leukemia & lymphoma/Leukemia and lymphoma	2011	99
Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromes Pellegrino Musto, Oreste Villani, Maria Carmen Martorelli, Leukemia Research Hematological MalignancyErythropoietin AlphaBone Marrow FailureGranulocyte-colony Stimulating FactorAplastic Anemia	2009	29
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions Adele Bolognese, Anna Esposito, Michele Manfra, Advances in Hematology Pharmaceutical ScienceBioorganic ChemistryPharmacotherapyPharmaceutical ChemistryButyl-boronic Acid	2009	17
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study Danilo De Novellis, Raffaele Fontana, Angela Carobene, Biomedicines Renal PathologyPathologyFlc RatioHematological MalignancyGlomerulonephritis	2022	16
Chronic Lymphocytic Leukemia After Chronic Myeloid Leukemia in the Same Patient: Two Different Genomic Events and a Common Treatment? Giovanni D’Arena, Marica Gemei, Luigiana Luciano, Journal of Clinical Oncology Hematological MalignancyChronic Myeloid LeukemiaOncologyChronic Lymphocytic LeukemiaMedicine	2012	14
Final Results of a Phase II Study Evaluating Lenalidomide in Combination with Low Dose Dexamethasone As First Line Therapy for Primary Plasma Cell Leukemia Pellegrino Musto, Fiorella D’Auria, Maria Teresa Petrucci, Blood	2011	12
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens Luca Pezzullo, Valentina Giudice, Bianca Serio, Open Medicine	2021	12
Detection of increased left ventricular filling pressure by pulsed tissue Doppler in cardiac amyloidosis Pasquale Innelli, Maurizio Galderisi, Lucio Catalano, Journal of Cardiovascular Medicine	2006	10
Prophylactic letermovir decreases cytomegalovirus reactivation after stem cell transplantation: a single-center real-world evidence study. Bianca Serio, Valentina Giudice, Roberto Guariglia, PubMed	2021	10

Page 1